Regulon

Regulon: R-215

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
182.7296215Pr-140Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
29927 ENSG00000058262 SEC61A1 P61619
8974 ENSG00000072682 P4HA2 O15460
3783 ENSG00000104783 KCNN4 O15554
768 ENSG00000107159 CA9 Q16790
22943 ENSG00000107984 DKK1 O94907
24145 ENSG00000110218 PANX1 A0A024R397
1453 ENSG00000141551 CSNK1D P48730
8444 ENSG00000143479 DYRK3 O43781
5352 ENSG00000152952 PLOD2 O00469
3141 ENSG00000159267 HLCS P50747
9903 ENSG00000162413 KLHL21 Q9UJP4
2669 ENSG00000164949 GEM P55040
1200 ENSG00000166340 TPP1 O14773
2990 ENSG00000169919 GUSB P08236
3654 ENSG00000184216 IRAK1 P51617
113146 ENSG00000185567 AHNAK2 Q8IVF2
2650 ENSG00000187210 GCNT1 Q02742
4363 ENSG00000278183 ABCC1 A0A0A0MS99

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
SULTHIAMECA2Small moleculeINHIBITORCarbonic anhydrase inhibitor40
SENICAPOCKCNN4Small moleculeBLOCKERIntermediate conductance calcium-activated potassium channel protein 4 blocker30
DKN-01DKK1UnknownINHIBITORDickkopf-related protein 1 inhibitor20
CG250 177LUCA9AntibodyBINDING AGENTCarbonic anhydrase IX binding agent30
GIRENTUXIMABCA9AntibodyOTHERCarbonic anhydrase IX other30
CG250 111INCA9AntibodyBINDING AGENTCarbonic anhydrase IX binding agent30
BHQ-880DKK1AntibodyINHIBITORDickkopf-related protein 1 inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-215

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-05079SPEGdown-regulatesJUNactivatesR-215257Drugs (7)

Regulator Drugs (0)

Regulon Drugs (7)

SULTHIAME, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, BHQ-880

CMF-05888FAM71Bdown-regulatesJUNactivatesR-215251Drugs (7)

Regulator Drugs (0)

Regulon Drugs (7)

SULTHIAME, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, BHQ-880

CMF-09025NALCNdown-regulatesJUNactivatesR-215257Drugs (7)

Regulator Drugs (0)

Regulon Drugs (7)

SULTHIAME, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, BHQ-880

CMF-19361NF1up-regulatesJUNactivatesR-2152516Drugs (7)

Regulator Drugs (0)

Regulon Drugs (7)

SULTHIAME, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, BHQ-880

CMF-29871ABCC9up-regulatesJUNactivatesR-215258Drugs (7)

Regulator Drugs (0)

Regulon Drugs (7)

SULTHIAME, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, BHQ-880